Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"RN7SK pseudogene 264" is annotated as a pseudogene—an inactive, non-coding RNA gene related in sequence to the functional RN7SK gene (*RNA, 7SK small nuclear*). Pseudogenes do not usually encode functional products nor are they known to play roles as therapeutic targets. The functional RN7SK gene encodes the 7SK small nuclear RNA, a crucial component in the 7SK ribonucleoprotein (RNP) complex that regulates RNA polymerase II transcription via the sequestration and inactivation of positive transcription elongation factor b (P-TEFb)[3][5]. Dysregulation of the active 7SK RNA is connected to transcriptional misregulation in multiple diseases, but no such roles are described for its pseudogenes. There are no reported drug interactions, biomarkers, or disease associations for RN7SK pseudogenes.\n\nClarifying note:\n- The entry is **not a canonical therapeutic target**. The functional molecule of interest in the literature is *RN7SK small nuclear RNA* or \"RNA, 7SK small nuclear\" (abbreviated \"RN7SK\" or \"7SK\"), not the pseudogene[3][5][6].\n- \"RN7SK pseudogene 264\" is most likely an automated or database-generated name for a pseudogene locus with no known function or targeting relevance.\n\nIf detailed information is desired for the **functional RN7SK gene**, a distinct and functionally rich summary can be provided (covering roles in transcription regulation, disease links, and relevant molecular complexes). However, \"RN7SK pseudogene 264\" itself is **not a characterized or actionable biological target**[3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 264 (RN7SKP264).